Rapydan

EUSA Pharma has launched Rapydan (lidocaine, tetracaine), a medicated plaster for surface anaesthesia.

Rapydan contains 70mg lidocaine and 70mg tetracaine, and is indicated for surface anaesthesia for needle puncture in adults and children from three years of age, and for superficial surgical procedures on normal intact skin in adults.

The recommended dose is one or up to a maximum of four plasters for adults and one or up to a maximum of two plasters for children. The anaesthetic plasters must be applied 30 minutes before the procedure.

View Rapydan drug record

Further information: EUSA Pharma

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more